Hysteroscopy Systems Market Analysis Repot By Product (Hysteroscopes, Hysteroscopy Fluid Management Systems, Hysteroscopic Tissue Removal Systems), By Modality (Benchtop Systems, Stand-Alone Systems, Handheld Systems), By Region - Global Market Forecast 2019-2027

Large Gynecological Disease Patient Pool Pointing to Robust Growth Opportunities

According to the Centers for Disease Control and Prevention (CDC), U.S., women are at risk for developing uterine cancers and the probability increases with age.

Furthermore, uterine fibroids (leiomyomas or myomas) are the most common benign pelvic tumours in women. It is estimated that 80% of women develop uterine fibroids during their lifetime. Similarly, unhealthy lifestyles are increasing the prevalence of polycystic ovary disease (PCOD) in adolescent women.

The aforementioned factors along with increased risk of postmenopausal complications in older women is expected to propel the hysteroscopy systems market growth during the forecast period.

Awareness for Hysteroscopy Procedures to Spike, on the Back of Increasing Reimbursement Policies

Gradual shift in reimbursement policies has pumped up the prevalence of hysteroscopy in office-based set-ups.

As per the report of national payment amounts, consumer spending on hysteroscopy procedures performed in office has increased threefold, accounting for an average of US$ 1,382.1 in 2017 as compared to US$ 409.6 in 2016.

Furthermore, increasing awareness among people is playing an important role in the overall growth of the market. Several awareness programs such as “My hysteroscope is my Stethoscope” are encouraging gynecologists to use hysteroscopy as a diagnostic tool.

In recent years, office-based hysteroscopes are gaining popularity, thus creating new and robust opportunities for growth of the hysteroscopy systems market.

North America and Europe to Maintain Hegemony as FDA Amps up Regulations

North America along with Europe together accounted for nearly half of the market share in the hysteroscopy systems market.

The increased adoption of hysteroscopy systems in the North America is attributable to the replacement of traditional methods with hysteroscopy and encouragement of office based hysteroscopy procedures.

This offers lucrative opportunities for growth of the market in these regions. Furthermore, initiatives by the regulatory authorities will further heighten the demand for hysteroscopy systems.

For instance, in April 2018, the FDA ordered restrictions on the sale and distribution of Essure, a device for female sterilization. This was done to ensure that all women are provided with adequate risk information to make informed decisions. Such directives will propel the market growth in these regions.

Hysteroscopy Systems Market Poised for Consolidation, Top Players Capture 80% Market Share

The hysteroscopy systems market is a consolidated market with top five companies holding a market share of nearly 80%. Most of the top players already have a strong foothold in the endoscopy market, as compared to newer participants. Although, these companies offer strong competition for new entrants.

Some companies such as Meditrina Inc. have been able to develop advanced products that will be launched into the market by the end of 2019. The hysteroscopy systems market currently holds ~6% of the endoscopy systems market. This trend is expected to change with hysteroscopy taking over 10% of the endoscopy market primarily due to the rapid adoption of hysteroscopy systems and replacement of traditional procedures with hysteroscopic procedures.

Acquisitions, a Key Trend Burgeoning Hysteroscopy System Market Growth

Most manufacturers are focusing on acquiring technology developed by competitors to enhance their product portfolio. Although the hysteroscopy systems market is consolidated, new players are working in the market by launching number of hysteroscopy systems and accessories

• In 2016, Medtronic plc acquired Smith & Nephew's gynecology business for approximately US$350 million. Medtronic acquired TRUCLEAR System, Smith & Nephew's key GYN solution, through this agreement
• Meditrina Inc. founded in 2016, expects Aveta™ System to be launched by the end of 2019. After the FDA approval for Aveta, the company received US$ 13 Mn equity financing led by ShangBay Capital LLC and Aethan Capital, Inc. This reflects the growth potential the hysteroscopy systems market holds during the forecast period.

Key Segments of the Hysteroscopy Systems Market

Fact.MR’s study on the hysteroscopy systems market offers information divided into four important segments - Product, Modality, End User, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.